Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus

Journal of the American College of Cardiology

Volumn 30, Issue 4, 1997, Pages 935-941

  Akasaka, Takashi ^a   Yoshida, Kiyoshi ^a   Hozumi, Takeshi ^a   Takagi, Tsutomu ^a   Kaji, Shuichiro ^a   Kawamoto, Takahiro ^a   Morioka, Shigefumi ^a   Yoshikawa, Junichi ^b  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; CORONARY CIRCULATION; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART CATHETERIZATION; HUMANS; ISOSORBIDE DINITRATE; MALE; MICROCIRCULATION; MIDDLE AGED; VASODILATOR AGENTS;

EID: 0030880821     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00242-8     Document Type: Article

References (42)

1. Fein FS, Zonnenblich EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985;27:255-70.
2. Cannon RO III, Schenke WH, Leon MB, Rosing DR, Urqhart J, Epstein SE. Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. Circulation 1987;75:163-74.
3. Bradley AJ, Alpert JS. Coronary flow reserve. Am Heart J 1991;122:1116-28.
4. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali J. Impairment of coronary vascular reserve and Ach-induced coronary vasodilatation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993;42:1017-25.
5. Nahser PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995;91:635-40.
6. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes 1989;38: 1203-6.
7. Segal J, Kern MJ, Scott NA, et al. Alterations of phasic coronary artery flow velocity in humans during percutaneous coronary angioplasty. J Am Coll Cardiol 1992;20:276-86.
8. Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-911.
9. Ofili EO, Labovitz AJ, Kern MJ. Coronary flow velocity dynamics in normal and diseased arteries. Am J Cardiol 1993;71:3D-9D.
10. Joye JD, Schulman DS, Lasorda D, Farah T, Donohue BC, Reichek N. Intracoronary Doppler guide wire versus stress single-photon emission computed tomographic thallium-201 imaging in assessment of intermediate coronary stenoses. J Am Coll Cardiol 1994;24:940-7.
11. Schiller NB, Skioldebrand CG, Schiller EJ, et al. Canine left ventricular mass estimation by two-dimensional echocardiography. Circulation 1983;68: 210-6.
12. Byrd III BF, Wahr D, Wang YS, Bouchard A, Schiller NB. Left ventricular mass and volume/mass ratio determined by two-dimensional echocardiography in normal adults. J Am Coll Cardiol 1985;6:1021-5.
13. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
14. Desmet W, De Scheerder I, Beatt K, Huehns T, Piessens J. In vivo comparison of different quantitative edge detection systems used for measuring coronary arterial diameters. Cathet Cardiovasc Diagn 1995;34:72-80.
15. Hausleiter J, Nolte CWT, Jost S, Weise B, Sturm M, Lichtlen PR. Comparison of different quantitative coronary analysis systems: ARTREK, CAAS, and CMS. Cathet Cardiovasc Diagn 1996;37:14-22.
16. Akasaka T, Yoshikawa J, Yoshida K, et al. Flow capacity of internal mammary artery grafts: early restriction and later improvement assessed by Doppler guide wire: comparison with saphenous vein grafts. J Am Coll Cardiol 1995;25:640-7.
17. Johonson LL, Sciacca RR, Ellis K, Weiss MB, Cannon PJ. Reduced left ventricular myocardial blood flow per unit mass in aortic stenosis. Circulation 1978;57:582-90.
18. Nitenberg A, Antony I. Epicardial coronary arteries are not adequately sized in hypertensive patients. J Am Coll Cardiol 1996;27:115-23.
19. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis aging, renal ablation and intrinsic renal injury. N Engl J Med 1982;307: 652-9.
20. Kohner EM, Hamilton AMP, Saunders SJ, Sutcliffe BA, Bulpitt CJ. The retinal blood flow in diabetes. Diabetologia 1975;11:27-33.
21. Doria A, Nosadini R, Avogaro A, Fioretto P, Crepaldi G. Myocardial metabolism in type 1 diabetic patients without coronary artery disease. Diabetic Med 1991;8:104-7.
22. Saudek CD, Eder HA. Lipid metabolism in diabetes mellitus. Am J Med 1979;66:843-52.
23. Vik-Mo H, Mjos OD. Influence of free fatty acids on myocardial oxygen consumption and ischemic injury. Am J Cardiol 1981;48:361-5.
24. Benson TJ, Nerem RM, Pedley TJ. Assessment of wall shear stress in arteries, applied to the coronary circulation. Cardiovasc Res 1980;14:568-76.
25. Vita JA, Treasure CB, Ganz P, Cox DA, Fish RD, Selwyn AP. Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis. J Am Coll Cardiol 1989;14:1193-9.
26. Carew TE, Patel DJ. Effect of tensile and shear stress on intimai permeability of the left coronary artery in dogs. Atherosclerosis 1973;18:179-89.
27. Tedgui A, Merval R, Esposito B. Albumin transport characteristics of rat aorta in early phase of hypertension. Circ Res 1992;71:932-42.
28. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488-500.
29. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979;59:8-13.
30. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979;241:2035-8.
31. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (Hb A1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-83.
32. McGinn AI, White CW, Wilson RF. Interstudy variability of coronary flow reserve: influence of heart rate, arterial pressure, and ventricular preload. Circulation 1990;81:1319-30.
33. Fitzgerald PJ, St. Goar FG, Connolly AJ, et al. Intravascular ultrasound imaging of coronary arteries: is three layers the norm? Circulation 1992;86: 154-8.
34. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol 1994;23:352-7.
35. Opherk D, Mall G, Zebe H, et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984;69:1-7.
36. Cannon RO, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985;71: 234-43.
37. Marcus ML, Doty DB, Hiratsuka LF, Wright CB, Eastham CL. Decreases coronary flow reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med 1982;307:1362-7.
38. Arora GD, Reeves WC, Movahed A, Jenks T. Alteration of coronary perfusion reserve in hypertensive patients with diabetes. J Hum Hypertens 1994;8:51-7.
39. Egashira K, Hirooka Y, Kai H, et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519-24.
40. Reis SE, Gloth ST, Blumenthal RS, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994;89:52-60.
41. Gilligan DM, Quyyumi AA, Cannon RO, Johnson GB, Schenke WH. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545-51.
42. Collins P, Rosano GMC, Sarrel PM, et al. 17-β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995;92:24-30.